Description
Making therapeutics innovation faster, cheaper, and easier by leveraging the power of human mini-organs, which recapitulate major human disease states. Applying this platform, they have discovered novel drugs to target polycystic kidney disease, a condition that affects 12,000,000 people worldwide with no known cure.
Team Members
Benjamin Freedman
CEO